Deep, qualified future-technology sequencing has exposed that subclonal mutations (i.e., All those existing in just a fraction of tumor cells) might be detected for all driver genes and they are associated with rapid ailment progression and poor outcome.11–13 This is especially pertinent for TP53 mutations supplied The point that, as https://ronz975uck3.blog-ezine.com/profile